These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 5987421)

  • 1. [Lessening of the action of sulfamethoxypyridine: cutaneous outbreak of previously cleared up lepromatous leprosy].
    Merklen FP; Cottenot F; Moulias R
    Bull Soc Fr Dermatol Syphiligr; 1966; 73(5):473. PubMed ID: 5987421
    [No Abstract]   [Full Text] [Related]  

  • 2. [Quadriplegia, in lepromatous leprosy previously cleared-up, diffuse polyneuritis which appeared in spite of 6 years of follow-up consolidating treatment with Sultirene alone].
    Merklen FP; Cottenot F; Pennec J; Vernant JC; Buzacoux J
    Bull Soc Fr Dermatol Syphiligr; 1971; 78(4):461-2. PubMed ID: 5150887
    [No Abstract]   [Full Text] [Related]  

  • 3. [Value of the combination of 4-aminoquinoline and sulfamethoxypyridazine in treatment of the tuberculoid form of Hansen's disease. Results obtained after 5 years of observation].
    Chum-Chantholl
    Bull Soc Pathol Exot Filiales; 1968; 61(4):504-10. PubMed ID: 5756653
    [No Abstract]   [Full Text] [Related]  

  • 4. [Comments on 9 cases of lepromatous leprosy].
    Puissant A; Pringuet R; Pradinaud R
    Bull Soc Fr Dermatol Syphiligr; 1968; 75(1):20-6. PubMed ID: 5674296
    [No Abstract]   [Full Text] [Related]  

  • 5. [Late evolutive recurrences of formerly treated leprosy].
    Merklen FP; Cottenot F; Pennec J; Blanchet P
    Bull Soc Fr Dermatol Syphiligr; 1971; 78(4):459-61. PubMed ID: 5170176
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of Hansen's disease with delayed-action sulfamides].
    Languillon J
    Dermatol Int; 1968; 7(2):84-9. PubMed ID: 5741774
    [No Abstract]   [Full Text] [Related]  

  • 7. [Present-day specific therapeutic drugs for leprosy].
    Languillon J
    Med Trop (Mars); 1966; 26():Suppl 26:131+. PubMed ID: 4864601
    [No Abstract]   [Full Text] [Related]  

  • 8. [Failure of thalidomide treatment in a case of leprous erythema multiforme].
    Duperrat B; Puissant A; Pringuet R; Revuz J; Lauret P; Ghezzi
    Bull Soc Fr Dermatol Syphiligr; 1968; 75(6):736-7. PubMed ID: 5712975
    [No Abstract]   [Full Text] [Related]  

  • 9. Thalidomide in leprosy therapy.
    Mohr W
    Int J Lepr Other Mycobact Dis; 1971; 39(2):598-9. PubMed ID: 4948096
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pharmacokinetics].
    Med Monatsschr; 1967 Aug; 21(8):339-40. PubMed ID: 5597095
    [No Abstract]   [Full Text] [Related]  

  • 11. Incidations for thalidomide therapy for leprosy.
    Klüken N; Wente W
    Int J Dermatol; 1974; 13(1):20-5. PubMed ID: 4813518
    [No Abstract]   [Full Text] [Related]  

  • 12. [LEPROMATOUS LEPROSY WITH HEPATIC LOCALIZATION].
    BETOURNE C; VALLIN J; GENTILINI M; HAYEM F
    Bull Mem Soc Med Hop Paris; 1964 Mar; 115():535-40. PubMed ID: 14162062
    [No Abstract]   [Full Text] [Related]  

  • 13. [Trial treatment of lepromatous leprosy by sulfamethopyrazine].
    LITALIEN F; HARTER P; TRINH THI KIM MONG DON ; NGUYEN THI LAU
    Bull Soc Pathol Exot Filiales; 1961; 54():219-31. PubMed ID: 13762698
    [No Abstract]   [Full Text] [Related]  

  • 14. [The treatment of leprosy].
    Degos R
    Dermatol Int; 1968; 7(2):81-3. PubMed ID: 5754554
    [No Abstract]   [Full Text] [Related]  

  • 15. [Sulfamethopyrazine in the treatment of leprosy].
    Lima Filueira A
    Rev Bras Med; 1970 Mar; 27(3):157-8. PubMed ID: 5504865
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of treatment on the cellular composition of cutaneous lesions in leprosy patients.
    Sarno EN; Kaplan G; Alvaranga F; Nogueira N; Porto JA; Cohn ZA
    Int J Lepr Other Mycobact Dis; 1984 Dec; 52(4):496-500. PubMed ID: 6336043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of 9 months of treatment of lepromatous leprosy with desoxyfructo-serotonin].
    Saint-André P; Baquillon G; Mester de Parajd L; Mester de Parajd M
    Acta Leprol; 1982; (86-87):189-97. PubMed ID: 6815988
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of single dose (1500 mg) rifampicin on infectivity of patients with lepromatous leprosy.
    Girdhar BK; Sreevatsa ; Desikan KV
    Lepr India; 1980 Jul; 52(3):359-65. PubMed ID: 7206633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutaneous delayed-type hypersensitivity responsiveness in lepromatous and borderline lepromatous leprosy patients as determined by MULTITEST CMI.
    Walsh DS; Villahermosa LG; Balagon MV; Abalos RM; Fajardo TT; Tan EV; Cellona RV; Walsh GP
    Southeast Asian J Trop Med Public Health; 1999 Sep; 30(3):518-26. PubMed ID: 10774662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of minocycline in single dose and at 100 mg twice daily for lepromatous leprosy.
    Gelber RH; Murray LP; Siu P; Tsang M; Rea TH
    Int J Lepr Other Mycobact Dis; 1994 Dec; 62(4):568-73. PubMed ID: 7868955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.